Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity

Patent No. EP3564267 (titled "Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity") was filed by CSL Behring on Jun 14, 2007. The application was issued on Mar 17, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SWEDISH ORPHAN BIOVITRUMDec 17, 2021AWA SWEDEN
SANOFIDec 16, 2021ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3564267

CSL BEHRING
Application Number
EP19162362A
Filing Date
Jun 14, 2007
Status
Granted And Under Opposition
Feb 12, 2021
Publication Date
Mar 17, 2021